Neoadjuvant FinHer regimen in patients with HER2-positive breast cancer: a retrospective audit - Poll - MDSpire

Neoadjuvant FinHer regimen in patients with HER2-positive breast cancer: a retrospective audit

  • By

  • Anoop T. M.

  • Rona Joseph

  • Sherin Mathew

  • Mintu Mathew

  • Saikumar Soman

  • Kalai Bharathi

  • Senthamizhan S

  • May 18, 2026

  • 0 min

Share

Original Source(s)

Neoadjuvant FinHer regimen in patients with HER2-positive breast cancer: a retrospective audit

  • by Anoop T. M., Rona Joseph, Sherin Mathew, Mintu Mathew, Saikumar Soman, Kalai Bharathi, Senthamizhan S

  • May 18, 2026

Related Content

Bilateral renal metastasis following radical prostatectomy for prostate cancer: a case report

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer

Recurrent IDH-mutant astrocytoma WHO grade 4 diagnosed during pregnancy: case report with literature review